Innoviva, Inc. Common Stock (INVA) is a publicly traded Healthcare sector company. As of September 23, 2026, INVA trades at $20.95 with a market cap of $1.52B and a P/E ratio of 4.15. INVA moved -0.14% today. Year to date, INVA is +4.95%; over the trailing twelve months it is +10.19%. Its 52-week range spans $16.52 to $25.15. Analyst consensus is strong buy with an average price target of $40.67. Rallies surfaces INVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for INVA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $20.95 |
| Market Cap | $1.52B |
| P/E Ratio | 4.15 |
| EPS | $5.07 |
| Dividend Yield | 0.25% |
| 52-Week High | $25.15 |
| 52-Week Low | $16.52 |
| Volume | 250.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $440.00M |
| Net Income | $357.24M |
| Gross Margin | 72.19% |
3 analysts cover INVA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.67.